Synbiobeta is a unique event which exemplifies the optimism and enthusiasm our industry has for building a better more sustainable world.
San Francisco, California (PRWEB) September 27, 2017
TeselaGen founder and CEO Mike Fero has been selected to speak at SynBioBeta SF 2017, the annual conference bringing together entrepreneurs, investors, and practitioners to drive the synthetic biology industry forward. Other speakers at the industry’s premier event include genetics pioneer George Church, computing entrepreneur and venture capitalist Vinod Khosla and one of the founders of synthetic biology, James Collins.
“We couldn’t be more excited for this year’s conference, which comes at a crucial moment for the synthetic biology industry as a whole,” said SynBioBeta founder and CEO John Cumbers. “In just the last ten years, the pace of innovation has increased dramatically, and the impact of biotechnology is beginning to be felt in all industries. At SynBioBeta SF 2017, we will take stock of where we are today, and explore the various ways synthetic biology will shape the future.”
Key themes at the SynBioBeta conference this year include biomaterials and consumer products, cell factories for biopharmaceuticals, big data and artificial intelligence meet biology, and innovations for ocean sustainability. Talks and panels will discuss the future of DNA synthesis, why protein is the killer app, investment opportunities throughout the industry and why all companies need to be thinking about a Bio-Strategy in order to be able to compete.
Dr. Michael Fero, Chief Executive Officer, TeselaGen, said, “TeselaGen has a laser-like focus on building scalable enterprise quality software so badly needed by this new industry. We have had a lot of recent quantifiable success helping our Industrial and AgTech customers, so it is great to be able to share our story with our friends and colleagues. Synbiobeta is a unique event which exemplifies the optimism and enthusiasm our industry has for building a better more sustainable world.”
TeselaGen has built a secure scalable enterprise quality software platform for synthetic biology, accelerating the development of medicines, improved crops, and sustainably sourced chemicals and materials. TeselaGen is privately held and is based in the software hub of San Francisco, CA. The company has received early recognition in the form of four US National Science Foundation funding awards, a US Department of Energy funding award and a Bio-IT World Best Practices Award. TeselaGen uses its proprietary Synthetic Evolution® technology for accelerate rapid prototyping of recombinant molecules. Follow TeselaGen on Twitter, and learn more at http://www.teselagen.com.
SynBioBeta is the leading community of entrepreneurs, investors, policy makers and enthusiasts devoted to the responsible growth of the synthetic biology field. They host international synthetic biology conferences and events that bring the entire community together several times each year, giving anyone the opportunity to meet with the bright minds building and shaping the bio economy. SynBioBeta also offers a highly specialized weekly industry e-digest, news blog and educational courses in addition to providing companies in the industry with opportunities for advertising, exhibition and sponsorships for promotion. For more information, visit http://www.synbiobeta.com.